2018-2023 Global Age Related Macular Degeneration (AMD) Market Report (Status and Outlook)

September 2018 | 118 pages | ID: 2F709B2EE4AEN
LP Information

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

In this report, LP Information studies the present scenario (with the base year being 2017) and the growth prospects of global Age Related Macular Degeneration (AMD) market for 2018-2023.

Age related macular degeneration (AMD) is a condition wherein the macula the small central area of the retina in the eye is deteriorated.
Over the next five years, LPI(LP Information) projects that Age Related Macular Degeneration (AMD) will register a xx% CAGR in terms of revenue, reach US$ xx million by 2023, from US$ xx million in 2017.

This report presents a comprehensive overview, market shares and growth opportunities of Age Related Macular Degeneration (AMD) market by product type, application, key companies and key regions.

To calculate the market size, LP Information considers value generated from the sales of the following segments:

Segmentation by product type:

• Wet AMD
• Dry AMD

Segmentation by application:

• Men
• Woman

We can also provide the customized separate regional or country-level reports, for the following regions:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Spain
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report:

• Bayer
• F. HoffmannLa Roche
• Regeneron
• Novartis
• Valeant
• Pfizer
• ...

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives

• To study and analyze the global Age Related Macular Degeneration (AMD) market size by key regions/countries, product type and application, history data from 2013 to 2017, and forecast to 2023.
• To understand the structure of Age Related Macular Degeneration (AMD) market by identifying its various subsegments.
• Focuses on the key global Age Related Macular Degeneration (AMD) players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
• To analyze the Age Related Macular Degeneration (AMD) with respect to individual growth trends, future prospects, and their contribution to the total market.
• To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
• To project the size of Age Related Macular Degeneration (AMD) submarkets, with respect to key regions (along with their respective key countries).
• To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.
• To strategically profile the key players and comprehensively analyze their growth strategies.

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Age Related Macular Degeneration (AMD) Market Size 2013-2023
  2.1.2 Age Related Macular Degeneration (AMD) Market Size CAGR by Region
2.2 Age Related Macular Degeneration (AMD) Segment by Type
  2.2.1 Wet AMD
  2.2.2 Dry AMD
2.3 Age Related Macular Degeneration (AMD) Market Size by Type
  2.3.1 Global Age Related Macular Degeneration (AMD) Market Size Market Share by Type (2013-2018)
  2.3.2 Global Age Related Macular Degeneration (AMD) Market Size Growth Rate by Type (2013-2018)
2.4 Age Related Macular Degeneration (AMD) Segment by Application
  2.4.1 Men
  2.4.2 Woman
2.5 Age Related Macular Degeneration (AMD) Market Size by Application
  2.5.1 Global Age Related Macular Degeneration (AMD) Market Size Market Share by Application (2013-2018)
  2.5.2 Global Age Related Macular Degeneration (AMD) Market Size Growth Rate by Application (2013-2018)

3 GLOBAL AGE RELATED MACULAR DEGENERATION (AMD) BY PLAYERS

3.1 Global Age Related Macular Degeneration (AMD) Market Size Market Share by Players
  3.1.1 Global Age Related Macular Degeneration (AMD) Market Size by Players (2016-2018)
  3.1.2 Global Age Related Macular Degeneration (AMD) Market Size Market Share by Players (2016-2018)
3.2 Global Age Related Macular Degeneration (AMD) Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 AGE RELATED MACULAR DEGENERATION (AMD) BY REGIONS

4.1 Age Related Macular Degeneration (AMD) Market Size by Regions
4.2 Americas Age Related Macular Degeneration (AMD) Market Size Growth
4.3 APAC Age Related Macular Degeneration (AMD) Market Size Growth
4.4 Europe Age Related Macular Degeneration (AMD) Market Size Growth
4.5 Middle East & Africa Age Related Macular Degeneration (AMD) Market Size Growth

5 AMERICAS

5.1 Americas Age Related Macular Degeneration (AMD) Market Size by Countries
5.2 Americas Age Related Macular Degeneration (AMD) Market Size by Type
5.3 Americas Age Related Macular Degeneration (AMD) Market Size by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries

6 APAC

6.1 APAC Age Related Macular Degeneration (AMD) Market Size by Countries
6.2 APAC Age Related Macular Degeneration (AMD) Market Size by Type
6.3 APAC Age Related Macular Degeneration (AMD) Market Size by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries

7 EUROPE

7.1 Europe Age Related Macular Degeneration (AMD) by Countries
7.2 Europe Age Related Macular Degeneration (AMD) Market Size by Type
7.3 Europe Age Related Macular Degeneration (AMD) Market Size by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Age Related Macular Degeneration (AMD) by Countries
8.2 Middle East & Africa Age Related Macular Degeneration (AMD) Market Size by Type
8.3 Middle East & Africa Age Related Macular Degeneration (AMD) Market Size by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers and Impact
  9.1.1 Growing Demand from Key Regions
  9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 GLOBAL AGE RELATED MACULAR DEGENERATION (AMD) MARKET FORECAST

10.1 Global Age Related Macular Degeneration (AMD) Market Size Forecast (2018-2023)
10.2 Global Age Related Macular Degeneration (AMD) Forecast by Regions
  10.2.1 Global Age Related Macular Degeneration (AMD) Forecast by Regions (2018-2023)
  10.2.2 Americas Market Forecast
  10.2.3 APAC Market Forecast
  10.2.4 Europe Market Forecast
  10.2.5 Middle East & Africa Market Forecast
10.3 Americas Forecast by Countries
  10.3.1 United States Market Forecast
  10.3.2 Canada Market Forecast
  10.3.3 Mexico Market Forecast
  10.3.4 Brazil Market Forecast
10.4 APAC Forecast by Countries
  10.4.1 China Market Forecast
  10.4.2 Japan Market Forecast
  10.4.3 Korea Market Forecast
  10.4.4 Southeast Asia Market Forecast
  10.4.5 India Market Forecast
  10.4.6 Australia Market Forecast
10.5 Europe Forecast by Countries
  10.5.1 Germany Market Forecast
  10.5.2 France Market Forecast
  10.5.3 UK Market Forecast
  10.5.4 Italy Market Forecast
  10.5.5 Russia Market Forecast
  10.5.6 Spain Market Forecast
10.6 Middle East & Africa Forecast by Countries
  10.6.1 Egypt Market Forecast
  10.6.2 South Africa Market Forecast
  10.6.3 Israel Market Forecast
  10.6.4 Turkey Market Forecast
  10.6.5 GCC Countries Market Forecast
10.7 Global Age Related Macular Degeneration (AMD) Forecast by Type
10.8 Global Age Related Macular Degeneration (AMD) Forecast by Application

11 KEY PLAYERS ANALYSIS

11.1 Bayer
  11.1.1 Company Details
  11.1.2 Age Related Macular Degeneration (AMD) Product Offered
  11.1.3 Bayer Age Related Macular Degeneration (AMD) Revenue, Gross Margin and Market Share (2016-2018)
  11.1.4 Main Business Overview
  11.1.5 Bayer News
11.2 F. HoffmannLa Roche
  11.2.1 Company Details
  11.2.2 Age Related Macular Degeneration (AMD) Product Offered
  11.2.3 F. HoffmannLa Roche Age Related Macular Degeneration (AMD) Revenue, Gross Margin and Market Share (2016-2018)
  11.2.4 Main Business Overview
  11.2.5 F. HoffmannLa Roche News
11.3 Regeneron
  11.3.1 Company Details
  11.3.2 Age Related Macular Degeneration (AMD) Product Offered
  11.3.3 Regeneron Age Related Macular Degeneration (AMD) Revenue, Gross Margin and Market Share (2016-2018)
  11.3.4 Main Business Overview
  11.3.5 Regeneron News
11.4 Novartis
  11.4.1 Company Details
  11.4.2 Age Related Macular Degeneration (AMD) Product Offered
  11.4.3 Novartis Age Related Macular Degeneration (AMD) Revenue, Gross Margin and Market Share (2016-2018)
  11.4.4 Main Business Overview
  11.4.5 Novartis News
11.5 Valeant
  11.5.1 Company Details
  11.5.2 Age Related Macular Degeneration (AMD) Product Offered
  11.5.3 Valeant Age Related Macular Degeneration (AMD) Revenue, Gross Margin and Market Share (2016-2018)
  11.5.4 Main Business Overview
  11.5.5 Valeant News
11.6 Pfizer
  11.6.1 Company Details
  11.6.2 Age Related Macular Degeneration (AMD) Product Offered
  11.6.3 Pfizer Age Related Macular Degeneration (AMD) Revenue, Gross Margin and Market Share (2016-2018)
  11.6.4 Main Business Overview
  11.6.5 Pfizer News

...

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES AND FIGURES

Table Product Specifications of Age Related Macular Degeneration (AMD)
Figure Age Related Macular Degeneration (AMD) Report Years Considered
Figure Market Research Methodology
Figure Global Age Related Macular Degeneration (AMD) Market Size Growth Rate 2013-2023 ($ Millions)
Table Age Related Macular Degeneration (AMD) Market Size CAGR by Region 2013-2023 ($ Millions)
Table Major Players of Wet AMD
Table Major Players of Dry AMD
Table Market Size by Type (2013-2018) ($ Millions)
Table Global Age Related Macular Degeneration (AMD) Market Size Market Share by Type (2013-2018)
Figure Global Age Related Macular Degeneration (AMD) Market Size Market Share by Type (2013-2018)
Figure Global Wet AMD Market Size Growth Rate
Figure Global Dry AMD Market Size Growth Rate
Figure Age Related Macular Degeneration (AMD) Consumed in Men
Figure Global Age Related Macular Degeneration (AMD) Market: Men (2013-2018) ($ Millions)
Figure Global Men YoY Growth ($ Millions)
Figure Age Related Macular Degeneration (AMD) Consumed in Woman
Figure Global Age Related Macular Degeneration (AMD) Market: Woman (2013-2018) ($ Millions)
Figure Global Woman YoY Growth ($ Millions)
Table Global Age Related Macular Degeneration (AMD) Market Size by Application (2013-2018) ($ Millions)
Table Global Age Related Macular Degeneration (AMD) Market Size Market Share by Application (2013-2018)
Figure Global Age Related Macular Degeneration (AMD) Market Size Market Share by Application (2013-2018)
Figure Global Age Related Macular Degeneration (AMD) Market Size in Men Growth Rate
Figure Global Age Related Macular Degeneration (AMD) Market Size in Woman Growth Rate
Table Global Age Related Macular Degeneration (AMD) Revenue by Players (2016-2018) ($ Millions)
Table Global Age Related Macular Degeneration (AMD) Revenue Market Share by Players (2016-2018)
Figure Global Age Related Macular Degeneration (AMD) Revenue Market Share by Players in 2017
Table Global Age Related Macular Degeneration (AMD) Key Players Head office and Products Offered
Table Age Related Macular Degeneration (AMD) Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
Table Global Age Related Macular Degeneration (AMD) Market Size by Regions 2013-2018 ($ Millions)
Table Global Age Related Macular Degeneration (AMD) Market Size Market Share by Regions 2013-2018
Figure Global Age Related Macular Degeneration (AMD) Market Size Market Share by Regions 2013-2018
Figure Americas Age Related Macular Degeneration (AMD) Market Size 2013-2018 ($ Millions)
Figure APAC Age Related Macular Degeneration (AMD) Market Size 2013-2018 ($ Millions)
Figure Europe Age Related Macular Degeneration (AMD) Market Size 2013-2018 ($ Millions)
Figure Middle East & Africa Age Related Macular Degeneration (AMD) Market Size 2013-2018 ($ Millions)
Table Americas Age Related Macular Degeneration (AMD) Market Size by Countries (2013-2018) ($ Millions)
Table Americas Age Related Macular Degeneration (AMD) Market Size Market Share by Countries (2013-2018)
Figure Americas Age Related Macular Degeneration (AMD) Market Size Market Share by Countries in 2017
Table Americas Age Related Macular Degeneration (AMD) Market Size by Type (2013-2018) ($ Millions)
Table Americas Age Related Macular Degeneration (AMD) Market Size Market Share by Type (2013-2018)
Figure Americas Age Related Macular Degeneration (AMD) Market Size Market Share by Type in 2017
Table Americas Age Related Macular Degeneration (AMD) Market Size by Application (2013-2018) ($ Millions)
Table Americas Age Related Macular Degeneration (AMD) Market Size Market Share by Application (2013-2018)
Figure Americas Age Related Macular Degeneration (AMD) Market Size Market Share by Application in 2017
Figure United States Age Related Macular Degeneration (AMD) Market Size Growth 2013-2018 ($ Millions)
Figure Canada Age Related Macular Degeneration (AMD) Market Size Growth 2013-2018 ($ Millions)
Figure Mexico Age Related Macular Degeneration (AMD) Market Size Growth 2013-2018 ($ Millions)
Table APAC Age Related Macular Degeneration (AMD) Market Size by Countries (2013-2018) ($ Millions)
Table APAC Age Related Macular Degeneration (AMD) Market Size Market Share by Countries (2013-2018)
Figure APAC Age Related Macular Degeneration (AMD) Market Size Market Share by Countries in 2017
Table APAC Age Related Macular Degeneration (AMD) Market Size by Type (2013-2018) ($ Millions)
Table APAC Age Related Macular Degeneration (AMD) Market Size Market Share by Type (2013-2018)
Figure APAC Age Related Macular Degeneration (AMD) Market Size Market Share by Type in 2017
Table APAC Age Related Macular Degeneration (AMD) Market Size by Application (2013-2018) ($ Millions)
Table APAC Age Related Macular Degeneration (AMD) Market Size Market Share by Application (2013-2018)
Figure APAC Age Related Macular Degeneration (AMD) Market Size Market Share by Application in 2017
Figure China Age Related Macular Degeneration (AMD) Market Size Growth 2013-2018 ($ Millions)
Figure Japan Age Related Macular Degeneration (AMD) Market Size Growth 2013-2018 ($ Millions)
Figure Korea Age Related Macular Degeneration (AMD) Market Size Growth 2013-2018 ($ Millions)
Figure Southeast Asia Age Related Macular Degeneration (AMD) Market Size Growth 2013-2018 ($ Millions)
Figure India Age Related Macular Degeneration (AMD) Market Size Growth 2013-2018 ($ Millions)
Figure Australia Age Related Macular Degeneration (AMD) Market Size Growth 2013-2018 ($ Millions)
Table Europe Age Related Macular Degeneration (AMD) Market Size by Countries (2013-2018) ($ Millions)
Table Europe Age Related Macular Degeneration (AMD) Market Size Market Share by Countries (2013-2018)
Figure Europe Age Related Macular Degeneration (AMD) Market Size Market Share by Countries in 2017
Table Europe Age Related Macular Degeneration (AMD) Market Size by Type (2013-2018) ($ Millions)
Table Europe Age Related Macular Degeneration (AMD) Market Size Market Share by Type (2013-2018)
Figure Europe Age Related Macular Degeneration (AMD) Market Size Market Share by Type in 2017
Table Europe Age Related Macular Degeneration (AMD) Market Size by Application (2013-2018) ($ Millions)
Table Europe Age Related Macular Degeneration (AMD) Market Size Market Share by Application (2013-2018)
Figure Europe Age Related Macular Degeneration (AMD) Market Size Market Share by Application in 2017
Figure Germany Age Related Macular Degeneration (AMD) Market Size Growth 2013-2018 ($ Millions)
Figure France Age Related Macular Degeneration (AMD) Market Size Growth 2013-2018 ($ Millions)
Figure UK Age Related Macular Degeneration (AMD) Market Size Growth 2013-2018 ($ Millions)
Figure Italy Age Related Macular Degeneration (AMD) Market Size Growth 2013-2018 ($ Millions)
Figure Russia Age Related Macular Degeneration (AMD) Market Size Growth 2013-2018 ($ Millions)
Figure Spain Age Related Macular Degeneration (AMD) Market Size Growth 2013-2018 ($ Millions)
Table Middle East & Africa Age Related Macular Degeneration (AMD) Market Size by Countries (2013-2018) ($ Millions)
Table Middle East & Africa Age Related Macular Degeneration (AMD) Market Size Market Share by Countries (2013-2018)
Figure Middle East & Africa Age Related Macular Degeneration (AMD) Market Size Market Share by Countries in 2017
Table Middle East & Africa Age Related Macular Degeneration (AMD) Market Size by Type (2013-2018) ($ Millions)
Table Middle East & Africa Age Related Macular Degeneration (AMD) Market Size Market Share by Type (2013-2018)
Figure Middle East & Africa Age Related Macular Degeneration (AMD) Market Size Market Share by Type in 2017
Table Middle East & Africa Age Related Macular Degeneration (AMD) Market Size by Application (2013-2018) ($ Millions)
Table Middle East & Africa Age Related Macular Degeneration (AMD) Market Size Market Share by Application (2013-2018)
Figure Middle East & Africa Age Related Macular Degeneration (AMD) Market Size Market Share by Application in 2017
Figure Egypt Age Related Macular Degeneration (AMD) Market Size Growth 2013-2018 ($ Millions)
Figure South Africa Age Related Macular Degeneration (AMD) Market Size Growth 2013-2018 ($ Millions)
Figure Israel Age Related Macular Degeneration (AMD) Market Size Growth 2013-2018 ($ Millions)
Figure Turkey Age Related Macular Degeneration (AMD) Market Size Growth 2013-2018 ($ Millions)
Figure GCC Countries Age Related Macular Degeneration (AMD) Market Size Growth 2013-2018 ($ Millions)
Figure Global Age Related Macular Degeneration (AMD) arket Size Forecast (2018-2023) ($ Millions)
Table Global Age Related Macular Degeneration (AMD) Market Size Forecast by Regions (2018-2023) ($ Millions)
Table Global Age Related Macular Degeneration (AMD) Market Size Market Share Forecast by Regions
Figure Americas Age Related Macular Degeneration (AMD) Market Size 2018-2023 ($ Millions)
Figure APAC Age Related Macular Degeneration (AMD) Market Size 2018-2023 ($ Millions)
Figure Europe Age Related Macular Degeneration (AMD) Market Size 2018-2023 ($ Millions)
Figure Middle East & Africa Age Related Macular Degeneration (AMD) Market Size 2018-2023 ($ Millions)
Figure United States Age Related Macular Degeneration (AMD) Market Size 2018-2023 ($ Millions)
Figure Canada Age Related Macular Degeneration (AMD) Market Size 2018-2023 ($ Millions)
Figure Mexico Age Related Macular Degeneration (AMD) Market Size 2018-2023 ($ Millions)
Figure Brazil Age Related Macular Degeneration (AMD) Market Size 2018-2023 ($ Millions)
Figure China Age Related Macular Degeneration (AMD) Market Size 2018-2023 ($ Millions)
Figure Japan Age Related Macular Degeneration (AMD) Market Size 2018-2023 ($ Millions)
Figure Korea Age Related Macular Degeneration (AMD) Market Size 2018-2023 ($ Millions)
Figure Southeast Asia Age Related Macular Degeneration (AMD) Market Size 2018-2023 ($ Millions)
Figure India Age Related Macular Degeneration (AMD) Market Size 2018-2023 ($ Millions)
Figure Australia Age Related Macular Degeneration (AMD) Market Size 2018-2023 ($ Millions)
Figure Germany Age Related Macular Degeneration (AMD) Market Size 2018-2023 ($ Millions)
Figure France Age Related Macular Degeneration (AMD) Market Size 2018-2023 ($ Millions)
Figure UK Age Related Macular Degeneration (AMD) Market Size 2018-2023 ($ Millions)
Figure Italy Age Related Macular Degeneration (AMD) Market Size 2018-2023 ($ Millions)
Figure Russia Age Related Macular Degeneration (AMD) Market Size 2018-2023 ($ Millions)
Figure Spain Age Related Macular Degeneration (AMD) Market Size 2018-2023 ($ Millions)
Figure Egypt Age Related Macular Degeneration (AMD) Market Size 2018-2023 ($ Millions)
Figure South Africa Age Related Macular Degeneration (AMD) Market Size 2018-2023 ($ Millions)
Figure Israel Age Related Macular Degeneration (AMD) Market Size 2018-2023 ($ Millions)
Figure Turkey Age Related Macular Degeneration (AMD) Market Size 2018-2023 ($ Millions)
Figure GCC Countries Age Related Macular Degeneration (AMD) Market Size 2018-2023 ($ Millions)
Table Global Age Related Macular Degeneration (AMD) Market Size Forecast by Type (2018-2023) ($ Millions)
Table Global Age Related Macular Degeneration (AMD) Market Size Market Share Forecast by Type (2018-2023)
Table Global Age Related Macular Degeneration (AMD) Market Size Forecast by Application (2018-2023) ($ Millions)
Table Global Age Related Macular Degeneration (AMD) Market Size Market Share Forecast by Application (2018-2023)
Table Bayer Basic Information, Head Office, Major Market Areas and Its Competitors
Table Bayer Age Related Macular Degeneration (AMD) Revenue and Gross Margin (2016-2018)
Figure Bayer Age Related Macular Degeneration (AMD) Market Share (2016-2018)
Table F. HoffmannLa Roche Basic Information, Head Office, Major Market Areas and Its Competitors
Table F. HoffmannLa Roche Age Related Macular Degeneration (AMD) Revenue and Gross Margin (2016-2018)
Figure F. HoffmannLa Roche Age Related Macular Degeneration (AMD) Market Share (2016-2018)
Table Regeneron Basic Information, Head Office, Major Market Areas and Its Competitors
Table Regeneron Age Related Macular Degeneration (AMD) Revenue and Gross Margin (2016-2018)
Figure Regeneron Age Related Macular Degeneration (AMD) Market Share (2016-2018)
Table Novartis Basic Information, Head Office, Major Market Areas and Its Competitors
Table Novartis Age Related Macular Degeneration (AMD) Revenue and Gross Margin (2016-2018)
Figure Novartis Age Related Macular Degeneration (AMD) Market Share (2016-2018)
Table Valeant Basic Information, Head Office, Major Market Areas and Its Competitors
Table Valeant Age Related Macular Degeneration (AMD) Revenue and Gross Margin (2016-2018)
Figure Valeant Age Related Macular Degeneration (AMD) Market Share (2016-2018)
Table Pfizer Basic Information, Head Office, Major Market Areas and Its Competitors
Table Pfizer Age Related Macular Degeneration (AMD) Revenue and Gross Margin (2016-2018)
Figure Pfizer Age Related Macular Degeneration (AMD) Market Share (2016-2018)